Breathe easy: simple breathing technique tested to soothe Pre-Surgery jitters
NCT ID NCT03981731
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a combination of slow, guided breathing (called cardiac coherence) and a hypnosis session could help women feel less anxious before breast or gynecologic cancer surgery. Fifty-three women participated, practicing the breathing technique several times a day for a week before their operation. The main goal was to see if patients would actually follow the program, not yet to prove it reduces anxiety.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- guided breathing technique (cardiac coherence) and hypnosis session
- What this could lead to
- If it works, this could offer a simple, drug-free way to ease anxiety before cancer surgery and improve recovery.
- What could go wrong
- This was a small, early study with only 53 participants and no comparison group, so results may not be widely applicable. The main goal was to see if patients would stick with the program, not to prove it reduces anxiety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
53 people
The number who actually took part.
- Started
-
Feb 2020
- Finished
-
Jan 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age ≥ 18 years old 2. Surgery for breast or gynaecological cancer requiring scheduled hospitalization for up to 3 days 3. Signing of informed consent before any specific procedure in the study 4. Patient affiliated to a social security system Exclusion Criteria: 1. Patients undergoing outpatient surgery for their cancer will not be included 2. Natural bradycardia (50 beats per minute) 3. Patient taking β-blockers, digoxin, flecaine, isoptin, cordarone, diltiazem 4. Cardiac arrhythmias 5. Severe heart failure with ventricular ejection fraction \< 40% 6. Uncontrolled chronic pain 7. Patients whose medical or psychological conditions do not allow them to complete the study or sign the consent 8. Patient does not understand the French language 9. Deaf and/or dumb patient 10. Adult patient under guardianship or curatorship
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut régional du cancer de Montpellier
Montpellier, Hérault, 34298, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?